Investor
Centre
ZOONO GROUP LIMITED
Specialising in the development, manufacture and global distribution of a suite of unique, highly effective, long-lasting antibacterial products that have a distinct competitive advantage.
ZOONO Group has developed (and owns) a wealth of Intellectual Property based around the “ZOONO® Molecule” – it’s a unique antibacterial molecule that bonds to any surface (including hard surfaces, textiles, fabrics, skin etc) and kills a range of pathogens. Best of all, it has proven efficacy and longevity – it does not leach and cannot diminish in strength. Today, ZOONO Group has established a global network of customers and distributors spread across many countries and territories. As the market leader in its field, ZOONO Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.
MANAGEMENT
Board of Directors

Paul Hyslop
Managing Director / CEO

Don Clarke
Non-Executive Director

Elissa Hansen
Director/Company Secretary